Erratum: Transgenic upregulation of IK1 in the mouse heart is proarrhythmic (Basic Research Cardiology (2007) vol. 102 (412-428) 10.1007/s00395-007-0659-y);Transgenic upregulation of IK1 in the mouse heart is proarrhythmic

Basic Research in Cardiology

Volumn 102, Issue 5, 2007, Pages 416-428

  Piao, Lin ^a   Li, Jingdong ^a,b   McLerie, Meredith ^a   Lopatin, Anatoli N ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Arrhythmia; IK1; Kir2.1 channels; Transgenic mice

Indexed keywords

HALOTHANE; INWARDLY RECTIFYING POTASSIUM CHANNEL; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1; ISOPRENALINE; POTASSIUM ION; UNCLASSIFIED DRUG; CARDIOTONIC AGENT; INHALATION ANESTHETIC AGENT; KIR2.1 CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARRHYTHMOGENESIS; ARTICLE; ATRIOVENTRICULAR BLOCK; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM FIBRILLATION; HEART MUSCLE CELL; HEART MUSCLE EXCITABILITY; HEART MUSCLE POTENTIAL; HEART PROARRHYTHMIA; HEART REPOLARIZATION; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; HYPOKALEMIA; ISOLATED HEART; MALE; MOUSE; NONHUMAN; POTASSIUM CURRENT; SINUS ARREST; SUPRAVENTRICULAR TACHYCARDIA; TRANSGENIC MOUSE; UPREGULATION; WILD TYPE; ACTION POTENTIAL; ANIMAL; C57BL MOUSE; CATHETER ABLATION; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ELECTROCARDIOGRAPHY; GENETICS; HEART ARRHYTHMIA; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ACTION POTENTIALS; ANESTHETICS, INHALATION; ANIMALS; ARRHYTHMIAS, CARDIAC; CARDIOTONIC AGENTS; CATHETER ABLATION; ELECTROCARDIOGRAPHY; FEMALE; HALOTHANE; HYPOKALEMIA; ISOPROTERENOL; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; POTASSIUM CHANNELS, INWARDLY RECTIFYING; UP-REGULATION;

EID: 34548033028     PISSN: 03008428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00395-007-0679-7     Document Type: Erratum

References (45)

1. Antzelevitch C (2005) Role of transmural dispersion of repolarization in the genesis of drug-induced torsades de pointes. Heart Rhythm 2:S9-S15
2. Antzelevitch C, Fish J (2001) Electrical heterogeneity within the ventricular wall. Basic Res Cardiol 96:517-527
3. Asano Y, Davidenko JM, Baxter WT, Gray RA, Jalife J (1997) Optical mapping of drug-induced polymorphic arrhythmias and torsade de pointes in the isolated rabbit heart. J Am Coll Cardiol 29:831-842
4. Baker LC, London B, Choi BR, Koren G, Salama G (2000) Enhanced dispersion of repolarization and refractoriness in transgenic mouse hearts promotes reentrant ventricular tachycardia. Circ Res 86:396-407
5. Brachmann J, Scherlag BJ, Rosenshtraukh LV, Lazzara R (1983) Bradycardia- dependent triggered activity: Relevance to drug-induced multiform ventricular tachycardia. Circulation 68:846-856
6. Brooksby P,Levi AJ, Jones JV (1993) The electrophysiological characteristics of hypertrophied ventricular myocytes from the spontaneously hypertensive rat. J Hypertens 11:611-622
7. + Currents in Adult Mouse Ventricles. J Physiol 559(Pt 1):103-120
8. Chaves AA, Dech SJ, Nakayama T, Hamlin RL, Bauer JA, Carnes CA (2003) Age and anesthetic effects on murine electrocardiography. Life Sci 72:2401-2412
9. Dobrev D, Ravens U (2003) Remodeling of cardiomyocyte ion channels in human atrial fibrillation. Basic Res Cardiol 98:137-148
10. Dobrev D, Wettwer E, Kortner A, Knaut M, Schuler S, Ravens U (2002) Human inward rectifier potassium channels in chronic and postoperative atrial fibrillation. Cardiovasc Res 54:397-404
11. Drici MD, Baker L, Plan P, Barhanin J, Romey G, Salama G (2002) Mice display sex differences in halothane-induced polymorphic ventricular tachycardia. Circulation 106:497-503
12. Fabritz L, Kirchhof P, Franz MR, Eckardt L, Monnig G, Milberg P, Breithardt G, Haverkamp W (2003) Prolonged action potential durations, increased dispersion of repolarization, and polymorphic ventricular tachycardia in a mouse model of proarrhythmia. Basic Res Cardiol 98:25-32
13. Franz MR (1999) Current status of monophasic action potential recording: theories,measurements and interpretations. Cardiovasc Res 41:25-40
14. Guler N, Kati I, Demirel CB, Bilge M, Eryonucu B, Topal C (2001) The effects of volatile anesthetics on the Q-Tc interval. J Cardiothorac Vasc Anesth 15:188-191
15. Hirota K, Ito Y, Masuda A, Momose Y (1989) Effects of halothane on membrane ionic currents in guinea pig atrial and ventricular myocytes. Acta Anaesthesiol Scand 33:239-244
16. Hogan B (1994) Manipulating the mouse embryo. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory
17. Huang WY, Aramburu J, Douglas PS, Izumo S (2000) Transgenic expression of green fluorescence protein can cause dilated cardiomyopathy. Nat Med 6:482-483
18. Huneke R, Fassl J, Rossaint R, Luckhoff A (2004) Effects of volatile anesthetics on cardiac ion channels. Acta Anaesthesiol Scand 48:547-561
19. Kaab S, Nuss HB, Chiamvimonvat N, O'Rourke B, Pak PH, Kass DA, Marban E, Tomaselli GF (1996) Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure. Circ Res 78:262-273
20. Kleiman RB, Houser SR (1989) Outward currents in normal and hypertrophied feline ventricular myocytes. Am J Physiol 256:H1450-H1461
21. Knollmann BC, Katchman AN, Franz MR (2001) Monophasic action potential recordings from intact mouse heart: Validation, regional heterogeneity, and relation to refractoriness. J Cardiovasc Electrophysiol 12:1286-1294
22. Knollmann BC, Sirenko SG, Henriquez C, Franz MR (2003) Origin of the monophasic action potential: Which electrode? Pacing Clin Electrophysiol 26:996
23. Kondo M, Nesterenko V, Antzelevitch C (2004) Cellular basis for the monophasic action potential. Which electrode is the recording electrode? Cardiovasc Res 63:635-644
24. Li H, Guo W, Xu H, Hood R, Benedict AT, Nerbonne JM (2001) Functional expression of a GFP-tagged Kv1.5 alphasubunit in mouse ventricle. Am J Physiol Heart Circ Physiol 281:H1955-H1967
25. K1 in the mouse heart does not protect against acute metabolic challenges. Biophysical Journal (49th Annual Meeting, 2005) Part 2 Suppl. S 88:286A-286A
26. K1 in The Mouse Heart Leads to Multiple Abnormalities of Cardiac Excitability. Am J Physiol Heart Circ Physiol 287:H2790-2802
27. Liu HS, Jan MS, Chou CK, Chen PH, Ke NJ (1999) Is green fluorescent protein toxic to the living cells? Biochem Biophys Res Commun 260:712-717
28. Lopatin AN, Nichols CG (2001) Inward rectifiers in the heart: An update on I(K1). J Mol Cell Cardiol 33:625-638
29. McLerie M, Lopatin AN (2003) Dominant- negative suppression of I(K1) in the mouse heart leads to altered cardiac excitability. J Mol Cell Cardiol 35:367-378
30. Miake J, Marban E, Nuss HB (2002) Biological pacemaker created by gene transfer. Nature 419:132-133
31. Miake J, Marban E, Nuss HB (2003) Functional role of inward rectifier current in heart probed by Kir2.1 overexpression and dominant-negative suppression. J Clin Invest 111:1529-1536
32. Noujaim SF, Persaud D, Pandit SV, Munoz V, Auerbach D, Anumonwo J, Taffet S, Vikstrom k, Jalife J (2004) Overexpression of Kir2.1 protein channels in transgenic mice reduces conduction velocity and predisposes to stable reentrant arrhythmias. Circulation 110:III-152. Pos. 724
33. Plaster NM, Tawil R, Tristani-Firouzi M, Canun S, Bendahhou S, Tsunoda A, Donaldson MR, Iannaccone ST, Brunt E, Barohn R, Clark J, Deymeer F, George AL, Fish FA, Hahn A, Nitu A, Ozdemir C, Serdaroglu P, Subramony SH, Wolfe G, Fu Y, Ptacek LJ (2001) Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 105:511-519
34. Preisig-Muller R, Schlichthorl G, Goerge T, Heinen S, Bruggemann A, Rajan S, Derst C, Veh RW, Daut J (2002) Heteromerization of Kir2.x potassium channels contributes to the phenotype of Andersen's syndrome. Proc Natl Acad Sci USA 21:21
35. Priori SG, Pandit SV, Rivolta I, Berenfeld O, Ronchetti E, Dhamoon A, Napolitano C, Anumonwo J, Raffaele di Barletta M, Gudapakkam S, Bosi G, Stramba-Badiale M, Jalife J (2005) A Novel Form of Short QT Syndrome (SQT3) Is Caused by a Mutation in the KCNJ2 Gene. Circ Res 96:703-704
36. Satoh H, Delbridge LM, Blatter LA, Bers DM (1996) Surface: Volume relationship in cardiac myocytes studied with confocal microscopy and membrane capacitance measurements: Species-dependence and developmental effects. Biophys J 70:1494-1504
37. Spear JF, Moore EN (2000) Modulation of arrhythmias by isoproterenol in a rabbit heart model of d-sotalol-induced long Q-T intervals. Am J Physiol Heart Circ Physiol 279:H15-H25
38. Stadnicka A, Bosnjak ZJ, Kampine JP, Kwok WM (2000) Modulation of cardiac inward rectifier K(+)current by halothane and isoflurane. Anesth Analg 90:824-833
39. Taggart P, Sutton P, Chalabi Z, Boyett MR, Simon R, Elliott D, Gill JS (2003) Effect of adrenergic stimulation on action potential duration restitution in humans. Circulation 107:285-289
40. Tomaselli GF, Marban E (1999) Electrophysiological remodeling in hypertrophy and heart failure. Cardiovasc Res 42:270-283
41. Tong X, Porter LM, Liu G, Dhar-Chowdhury P, Srivastava S, Pountney DJ, Yoshida H, Artman M, Fishman GI, Yu C, Iyer R, Morley GE, Gutstein DE, Coetzee WA (2006) Consequences of Cardiac Myocyte-Specific Ablation of KATP channels in Transgenic Mice expressing Dominant Negative Kir6 Subunits. Am J Physiol Heart Circ Physiol 291:H543-H551
42. Tristani-Firouzi M, Jensen JL, Donaldson MR, Sansone V, Meola G, Hahn A, Bendahhou S, Kwiecinski H, Fidzianska A, Plaster N, Fu YH, Ptacek LJ, Tawil R (2002) Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome). J Clin Invest 110:381-388
43. Van Wagoner DR (2003) Electrophysiological remodeling in human atrial fibrillation. Pacing Clin Electrophysiol 26:1572-1575
44. Warren M, Guha PK, Berenfeld O, Zaitsev A, Anumonwo JM, Dhamoon AS, Bagwe S, Taffet SM, Jalife J (2003) Blockade of the inward rectifying potassium current terminates ventricular fibrillation in the guinea pig heart. J Cardiovasc Electrophysiol 14:621-631
45. Xia M, Jin Q, Bendahhou S, He Y, Larroque MM, Chen Y, Zhou Q, Yang Y, Liu Y, Liu B, Zhu Q, Zhou Y, Lin J, Liang B, Li L, Dong X, Pan Z, Wang R, Wan H, Qiu W, Xu W, Eurlings P, Barhanin J, Chen Y (2005) A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation. Biochem Biophys Res Commun 332:1012-1019